Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and AscitesFlorence Wong, K Rajender Reddy, Puneeta Tandon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 7, 2019
Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease ExperienceJacqueline G O'Leary, Jasmohan S Bajaj, Puneeta Tandon, et al.
Hepatology (Baltimore, Md.)|December 23, 2015
The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosisJasmohan S Bajaj, K Rajender Reddy, Puneeta Tandon, et al.
Gynecologic and Obstetric Investigation|August 22, 2008
Analysis of the association of preeclampsia with polymorphisms of the INS, INSR and IRS1 genes in Mexican womenMaria-Victoria Machorro-Lazo, Jose Sanchez-Corona, Esperanza Martínez-Abundis, et al.
Digestive Diseases and Sciences|November 13, 2020
Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic HydrothoraxJacqueline G O'Leary, K Rajender Reddy, Puneeta Tandon, et al.
Hepatology (Baltimore, Md.)|August 1, 2018
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal HypertensionGuadalupe Garcia-Tsao, Michael Fuchs, Mitchell Shiffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast CancerPaula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri, et al.
The American Journal of Gastroenterology|December 20, 2017
Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD CohortJasmohan S Bajaj, Rajender K Reddy, Puneeta Tandon, et al.
Gastroenterology|December 9, 2019
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal HypertensionNaga Chalasani, Manal F Abdelmalek, Guadalupe Garcia-Tsao, et al.
Hepatology (Baltimore, Md.)|January 10, 2018
NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosisJacqueline G O'Leary, K Rajender Reddy, Guadalupe Garcia-Tsao, et al.
Pageof 31